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Objective: This study aims to evaluate the long-term safety and efﬁcacy of laparoscopic staging surgery
(LSS) for endometrial cancer in Taiwanese women.
Materials and Methods: This is a longitudinal study of prospectively registered 105 patients who un-
derwent LSS for endometrial cancer between June 1995 and June 2008.
Results: The mean duration of surgery was 186.8 minutes, and the mean intraoperative blood loss was
220.38 mL. The median number of retrieved pelvic lymph nodes was 18. The intraoperative complication
rate was 4.8%, including two cases of ureteral injury and one case each of bladder injury, bowel injury,
and vascular injury. No patient required conversion to laparotomy. During the median follow-up of 55.3
months, six cases of recurrence (5.7%) and three tumor-related deaths (2.9%) were recorded. The 5-year
disease-free survival and the overall survival were 93.39% and 98.05%, respectively.
Conclusion: The study revealed favorable perioperative outcomes and better long-term survival than
reported in the Taiwan Cancer Registry, and similar good surgical results to those reported in the
Western studies. Therefore, LSS by experienced surgeons for endometrial cancer is a feasible and efﬁ-
cacious alternative to laparotomy.
Copyright  2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Endometrial cancer is one of the most common gynecologic
malignancies in the West and accounts for 6% of all cancers in
women [1]. Its incidence in the United States is 23.7 cases per
100,000 individuals [2]. In Taiwan, lifestyle-related changes in the
recent decades have led to a rise in the incidence of obesity and
metabolic syndrome-related diseases, which are potential risk
factors for endometrial cancer. The Bureau of Health Promotion
(Department of Health, Taipei, Taiwan) reported 302 new cases of
endometrial cancer in 1996 and 1165 in 2007, reﬂecting an increase
in the incidence from 2.5 cases to 8.3 cases per 100,000 individuals
in Taiwan [3]. Despite the increased incidence, there is no indica-
tion that Western and Asian women share similar patterns of
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bstetrics & Gynecology. PublishedWith the recent advances in laparoscopic equipment and knowl-
edge, laparoscopic surgery is widely accepted as safe and feasible for
managing benign gynecologic disease, and several authors have re-
ported laparoscopic approaches for the treatment of endometrial
cancer [4e12]. Laparoscopic staging surgery (LSS) for endometrial
cancer reportedly has some short-term advantages over the con-
ventional transabdominal surgery, suchas smaller incision, less tissue
reaction,meticulous hemostasis, decreased intraoperative blood loss,
less postoperative pain, and shorter hospital stay [1,2, 5,7,13]. How-
ever, thepaucityof long-termfollow-updatahas led togreat concerns
about the safety and efﬁcacy of LSS, which at the very least should
have equivalent outcomes to open surgery [6,13].
In this longitudinal study, we aimed to assess the long-term
outcome of LSS for endometrial cancer in Taiwanese women in
terms of disease-free survival, overall survival, and recurrence.
Materials and methods
Study population
Between June 1995 and June 2008, patients at Chang Gung
Memorial Hospital, Tao-Yuan, Taiwan, who had histologicallyby Elsevier Taiwan LLC. All rights reserved.
Table 1
Patient and tumor characteristics and surgical stage (N ¼ 105).
Age (y) 51.25  0.97
Median parity [median (interquartile range)] 3 (1, 4)
BMI (kg/m2) 26.78  0.56
Methods of diagnosis
Endometrial curettage 73 (69.5)
Hysteroscopic resection 28 (26.7)
Hysterectomy 4 (3.8)
FIGO staginga
IA 45 (42.9)
IB 34 (32.4)
IC 12 (11.4)
IIA 2 (1.9)
IIB 1 (0.9)
IIIA 2 (1.9)
IIIB 0 (0)
IIIC 9 (8.6)
Histology
Endometrioid carcinoma 99 (94.3)
Clear cell carcinoma 3 (2.6)
Serous papillary carcinoma 1 (0.9)
Adenosquamous carcinoma 2 (1.9)
Histologic grade
Grade 1 73 (69.5)
Grade 2 18 (17.1)
Grade 3 14 (13.3)
Positive cytology of peritoneal lavage
Present 0 (0)
Absent 105 (100)
Data are presented as n (%) or mean  SEM, unless otherwise indicated.
FIGO ¼ International Federation of Gynecology and Obstetrics; SEM ¼ standard
error of the mean.
a FIGO 1988 staging system.
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spread based on clinical assessment and who wished to undergo
LSS, were prospectively registered and followed up. Patients with
synchronous primary tumor at the time of surgery and those with
major medical conditions contraindicated for laparoscopic surgery,
such as severe cardiopulmonary disease, were excluded. Finally,
105 consecutive patients were enrolled.
All the enrolled patients gave their written informed consent
prior to surgery and speciﬁc permission for the use of their personal
health information for research purposes. The Human Investigation
Review Board of Chang Gung Memorial Hospital reviewed and
approved the study.
Surgical procedures
Two experienced surgeons (C.L.L. and K.G.H.) jointly performed
most of the surgeries, including peritoneal lavage, total hysterec-
tomy with bilateral salpingo-oophorectomy, and pelvic lympha-
denectomy. The current policy of our institution is to perform pelvic
and para-aortic lymphadenectomy in all patients with endometrial
cancer, according to the revised International Federation of Gyne-
cology and Obstetrics (FIGO) staging of 2009 [14]. Our study was
conducted prior to when the consensus for para-aortic lympha-
denectomy was established; thus, all the patients underwent pelvic
lymphadenectomy, but only patients with known risk factors of
metastasis, such as deep myometrial invasion and high-grade tu-
mor, underwent para-aortic lymph node dissection. Biopsy of sus-
picious lesions was performed after systemic inspection of the
peritoneal cavity. Omentectomy was performed for patients with
serous papillary carcinoma and clear cell carcinoma. In some pa-
tients of reproductive age (younger than 40 years) with early-stage
endometrial cancer, the ovaries were preserved after the patients
and their families were thoroughly counseled.
In most of the operations, ﬁve trocars were used, including two
12 mm and three 5 mm trocars. A 10 mm laparoscope was intro-
duced via a skin incision at the midpoint of the umbilicus and xi-
phoid process (LeeeHuang point) [15e17]. All other ancillary ports
were inserted laterally, as described previously [15e17]. Hysterec-
tomy was performed through a laparoscopic vaginal approach or a
total laparoscopic approach. The uterus was removed vaginally by
careful extraction and dissected as little as possible, without
entering the endometrial cavity.
Staging and adjuvant treatment
The ﬁnal surgical staging was based on the FIGO 1988 staging
system. Patients with FIGO stage IA grades 1e3 and FIGO stage IB
grade 1 underwent clinical observation. Those with FIGO stage IB
grades 2e3 and FIGO stage IC grades 1e2 underwent clinical
observation or received whole-pelvic radiation and vaginal
brachytherapy or chemotherapy, according to the adverse risk
factors. Further, those with FIGO stages IIA and IIB received whole-
pelvic radiation and/or vaginal brachytherapy. Patients with
advanced stages of endometrial cancer undertook adjuvant therapy
with radiotherapy, chemotherapy, or concurrent
chemoradiotherapy.
Follow-up examination
All the patients were recalled every 3 months for the ﬁrst 2
years, every 6 months for the next 3 years, and yearly thereafter. At
each visit, their clinical history was recorded, and physical and
pelvic examinations were performed along with a collection of
vaginal smears. Blood samples were collected for surveillance of
tumor markers, including CA125. Abdominopelvic computedtomography was performed 1 year after treatment or for suspected
recurrence. Other diagnostic procedures including ultrasonography
and biopsy were performed when indicated, such as for suspected
vaginal cuff and pelvic recurrence. Relapse was treated according to
the patient’s condition. After this treatment, the patients were
followed up as previously described.
Data collection and statistical analysis
The recorded surgical parameters were operation time; number
of retrieved lymph nodes; intraoperative blood loss; occurrence of
intraoperative and postoperative complications, blood transfusion,
and fever; and duration of hospitalization. Pathology data included
histology type, presence of lymphovascular space invasion (LVSI),
cytologic ﬁnding, and number of lymph nodes in the pelvic and
para-aortic areas. At the end of the study, the pattern of recurrence,
disease-free survival, and overall survival were analyzed.
All the data were analyzed using SPSS for Windows release
17.0.0/2008 (IBM-SPSS Inc., Chicago, IL, USA). Descriptive statistics,
such as mean, median, range, and percentage, were used to sum-
marize the data. The cumulative event rates (recurrence and death)
were calculated by the KaplaneMeier method, with the time to the
ﬁrst event as the variable.
Results
The patient characteristics and methods of initial diagnosis are
summarized in Table 1. Endometrial curettage was the most com-
mon method of initial diagnosis (69.5%), followed by hysteroscopic
resection (26.7%). Most of the patients (86.7%) had FIGO stage 1
cancer, and 13.34% were at an advanced stage mostly because of
lymph node metastasis (Table 1). From the histological ﬁndings, 73
patients (69.5%), 18 patients (17.1%), and 14 patients (13.3%) had
grade 1, grade 2, and grade 3 cancer, respectively, and the most
Table 3
Operation-related complications.
Type N (%) Treatment
Intraoperative
complication
5 (4.8)
Ureteral injury 2 Laparoscopic ureteroureteral
anastomosis/ureteroneocystomy
with D-J placement
Bladder injury 1 Laparoscopic suture repair
Bowel injury 1 Laparoscopic segmental resection
and reanastomosis
Vascular injury 1 Laparoscopic suture repair
with hemoclip
Postoperative
complications
4 (3.8)
UTI 2 Medical treatment
Voiding dysfunction 2 Foley training
UTI ¼ urinary tract infection.
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None of the patients had positive peritoneal lavage cytology ﬁnd-
ings during the ﬁnal staging surgery, including those who were
initially diagnosed by operative hysteroscopy.
The mean operation time was 186.8 minutes, and the mean
intraoperative blood loss was 220.38 mL (Table 2). All the patients
underwent pelvic lymphadenectomy, with the median number of
retrieved lymph nodes being 18. Para-aortic lymph node dissection
because of known risk factors was performed in 15 patients. None
of the patients required conversion to laparotomy. The mean
duration of hospitalization was 5.96 days. Overall, ﬁve patients
(4.8%) developed intraoperative complications, including ureteral
injury (n¼ 2), bladder injury (n¼ 1), bowel perforation (n¼ 1), and
vascular injury (n ¼ 1). The postoperative complications included
two events of urinary tract infection, requiring advanced antibiotic
treatment, and two events of voiding dysfunction, in which the
patients recovered after Foley training. Two patients received blood
transfusion (Table 3).
In total, 25 patients (24.0%) received adjuvant therapy accord-
ing to the ﬁnal surgical stages and adverse risk factors. Eleven
patients received radiotherapy alone (whole-pelvic radiotherapy
and/or vaginal cuff brachytherapy); eight patients received
chemotherapy alone; and six patients received concurrent che-
moradiotherapy. Fourteen patients were positive for LVSI in the
ﬁnal pathological examination. In this subgroup, 12 patients
received adjuvant therapy. Among those positive for LVSI, three
had recurrence, including one with FIGO stage IB grade 1 who did
not receive any adjuvant therapy and two with FIGO stage IC grade
3 and FIGO stage 1B grade 3, both of whom received whole-pelvic
radiotherapy.
The median follow-up duration was 55.3 months (mean, 67.24
months; interquartile range, 35.9e87.9 months). By the last follow-
up visit, recurrence was recorded in six patients (5.7%) and tumor-
related deaths in three (2.9%; Table 4). No port-site metastasis
occurred in this study. The 5-year disease-free survival and overall
survival rates were 93.39% and 98.05%, respectively (Fig. 1).
Discussion
Numerous case series on Western populations have advocated
the use of minimally invasive surgery for endometrial cancer, and
demonstrated comparable or even better short-term surgical out-
comes by laparoscopic surgery than the conventional trans-
abdominal approach [1,2,7,13,18]. However, to the best of our
knowledge, the present study is the ﬁrst long-term investigation on
the outcomes of LSS for endometrial cancer in Asian women. In
Korea, Cho et al [10] demonstrated less complications, shorter
duration of hospitalization, and no signiﬁcant change in recurrence
rate by laparoscopic surgery compared with laparotomy, but their
study had a shorter follow-up period (median duration, 28
months). Our patients were similar to those in previous studies inTable 2
Surgical outcomes.
Operation time (min) 186.8  6.2
Estimated blood loss (mL) 220.4  15.6
Ovarian preservation 10 (9.5)
Blood transfusion 2 (1.9)
Pelvic lymph node retrieval (no.) Median (int-Q range)
Right 8 (5e12)
Left 8 (5e12)
Para-aortic 7 (4e11)
Conversion to laparotomy (n) 0
Hospital stay (d) 5.96  0.28
Data are presented as n (%) or mean  SEM, unless otherwise indicated.
int-Q ¼ interquartile; SEM ¼ standard error of the mean.terms of age and ﬁnal stages (Table 1) [1,7,10e13]. By contrast, a
lower body mass index (BMI) and a higher proportion of endo-
metrioid tumor were found in our study. Several reports on the
Asian population have indicated that Asian women have a higher
body fat percentage and higher risk for metabolic disorders,
including those who have a similar BMI to that of Western women
[19,20]. The results might explain why the mean BMI in our group
and the previous Korean study is relatively less than that in
Western reports [10]. Of note, there seems to be a higher proportion
of endometrioid tumor in these two Asian studies compared with
Western reports [8,10,11]; thus, further studywith a larger database
is required to conﬁrm this trend.
About 25% of the patients underwent operative hysteroscopy
prior to LSS. Interestingly, none of the patients had any positive
cytologic ﬁndings from peritoneal lavage (Table 1), possibly
because of the low intrauterine pressure used for distension and
short duration of hysteroscopic examination. Therefore, we
conclude that hysteroscopy does not affect the positive rate of
peritoneal cytological results and survival after LSS by experienced
surgeons. This supports the previous reports that hysteroscopy
does not increase the risk of tumor spread into the peritoneal cavity
[2,21].
In our study, 15 patients had early-stage and grade 1 endome-
trioid carcinoma at the initial diagnosis and were of reproductive
age (younger than 40 years). After thorough counseling, 10 patients
underwent LSS with preservation of both ovaries because of con-
cerns about their postoperative hormonal status. No gross adnexal
lesion was identiﬁed during LSS. The ﬁnal surgical staging revealed
that one patient had FIGO stage IA cancer, eight had FIGO stage IB
cancer, and one had FIGO stage IC cancer. In those with FIGO stage
IB cancer, the depth of myometrial invasion was less than 15%. For
the patient with stage IC cancer, we arranged adjuvant chemo-
therapy, but the patient requested discontinuation after three
courses due to intolerable discomfort. These patients were followed
up by ultrasonography according to the study schedule. None of
them has experienced recurrence to date, although one patient had
a simple ovarian cyst (11 cm). During the following serial imaging
study, the tumor was found to decrease in size, and no surgical
intervention was performed. These results indicate that preserva-
tion of ovaries may be an alternative, after thorough counseling, for
carefully selected patients of reproductive age with endometrial
cancer.
The surgical outcomes of this study, especially the intra-
operative blood loss, number of retrieved lymph nodes, and intra-
operative complication rate (Tables 2 and 3), are comparable to
those of other studies [1,7,10e13]. The mean hospitalization dura-
tion was 5.96 days, which might be because of the culture of
Table 4
Recurrence.
Age Stage Histology Grade LVI Myom. Inv. (%) LN Met. Adj Site of recurrence Time to recur. (mo) Tx Status
Local Distant
1 53 IB Endometrioid 2 e 0 e e Lt supraclavicular node 11 CCRT DOD
2 55 IB Endometrioid 1 þ 40 e e First: vagina 11 First: CCRT AWD
Second: lung 28 Second: RT þ HT
3 60 IB Clear cell 3 þ 45 e e Rt ﬁbula bone 5 RT NED
4 38 IC Endometrioid 3 þ 50 e RT First: Lt kidney, PA node 13 First: OP þ CCRT DOD
Second: liver, spleen, bone 10 Second: CT
5 57 IC Endometrioid 2 e 50 e e Vagina 52 CCRT NED
6 80 IC Endometrioid 3 e 95 e RT Lung, PA node 17 RT NED
Adj ¼ adjuvant therapy; AWD ¼ alive with disease; CCRT ¼ concurrent chemoradiotherapy; CT ¼ chemotherapy; DOD ¼ died of disease; HT ¼ Hormone therapy; LN
Met ¼ lymph node metastasis; Lt ¼ left; LVI ¼ lymphovascular invasion; Myom. Inv. ¼myometrial invasion; NED ¼ no evidence of disease; OP¼ operation; PA¼ para-aortic;
Recur. ¼ recurrence; RT ¼ radiotherapy; Rt ¼ right; Tx ¼ treatment.
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of admission for oncological surgery, based on the recommenda-
tions of the National Health Insurance System. The intraoperative
complications included ureteral injury, which was repaired lapa-
roscopically with ureteroureteral anastomosis and ureter-
oneocystomy with the placement of D-J stents (2 patients); bladder
injury (1 patient); bowel perforation, which was repaired by
segmental resection and reanastomosis laparoscopically (1 pa-
tient); and vascular injury of the right external iliac artery during
lymph node dissection, which was secured with a hemoclip lapa-
roscopically. Conversion to laparotomywas not required, and all the
complications were successfully managed by laparoscopy. This
good surgical result is attributable to the use of the LeeeHuang
point for inserting the primary trocar, enabling a wider operative
ﬁeld and easier manipulation than with the conventional method
[15,16], and the cooperative and experienced surgical team for
managing gynecologic cancer [17].
The reported 5-year relative survival associated with endome-
trial cancer is around 79.5% in Taiwan [3]; therefore, our study
demonstrates favorable results (a 5-year disease-free survival rateFig. 1. KaplaneMeier plots showing percentage of (A) disease-free survival and (B)
overall survival (N ¼ 105). The starting point is the date of surgery, and each point on
the curve represents a ratio of terminating events to the total number of patients in the
respective interval. Terminating events were recurrence of cancer and tumor-related
death, which were used for calculating disease-free survival and overall survival,
respectively.of 93.39% and an overall survival rate of 98.05%; Fig. 1). These data
are comparable to those of several previous studies [13,22], sup-
porting the use of LSS for endometrial cancer.
In our study, six cases of recurrence (5.7%) were noted during
the follow-up (Table 4). All the patients with recurrent disease who
had initial FIGO stage IB cancer developed high-grade tumor or
LVSI, and none received adjuvant therapy. Among the patients with
FIGO stage IC cancer, one patient who had grade 2 tumor and did
not receive adjuvant therapy developed vaginal recurrence 52
months later. Two other patients who had grade 3 tumor and had
received radiotherapy developed distant metastasis in 13 months
and 17 months. Two patients developed vaginal recurrence at 11
months and 52 months, and both received concurrent chemo-
radiotherapy. They both experienced complete regression of the
vaginal mass after the adjuvant therapy, and there is no evidence of
disease in one patient to date. The other patient developed a second
metastasis in the lung at 28 months and received salvage therapy.
In earlier studies, the high rates of port-site metastasis and
positive peritoneal cytologic ﬁndings raised concerns about the
feasibility of LSS [23e25]. We encountered no case of port-site
metastases and no positive peritoneal cytologic ﬁndings, possibly
because we coagulated the fallopian tubes prior to any uterine
manipulation, as performed in some other studies [9], decreasing
the likelihood of tumor spread. Among the patients with LVSI, most
had advanced-stage cancer and received adjuvant therapy, and only
one patient with stage IC tumor experienced recurrence (Table 4).
By contrast, two patients who had stage 1B tumor and received no
adjuvant therapy developed recurrence, supporting the previous
result that LVSI is a risk factor for recurrence [26]. We recommend
adjuvant therapy in these patients.
The limitation of our report is that it is a single-arm case series,
which bears some inevitable weakness, such as confounding se-
lection and observer biases. Further randomized controlled studies
with long-term follow-ups are needed.
In conclusion, the present study is the ﬁrst long-term investi-
gation on the outcomes of LSS for endometrial cancer in Taiwanese
women. It revealed no obvious differences in the short-term sur-
gical outcomes from Western studies and demonstrated better
long-term outcomes than the reports of the Taiwan Cancer Registry.
Therefore, LSS by experienced surgeons for endometrial cancer has
favorable perioperative and long-term survival outcomes, and is an
ideal alternative to laparotomy with the advantages of minimal
invasiveness.
Ethics approval
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